Alcon Inc. (ALC)

USD 84.74

(-0.94%)

Operating Expenses Summary of Alcon Inc.

Alcon Inc.'s latest annual operating expenses in 2023 was 4.2 Billion USD , up 6.66% from previous year.
Alcon Inc.'s latest quarterly operating expenses in 2024 Q2 was 1.05 Billion USD , up 4.14% from previous quarter.
Alcon Inc. reported a annual operating expenses of 4.07 Billion USD in annual operating expenses 2022, up 0.1% from previous year.
Alcon Inc. reported a annual operating expenses of 4.07 Billion USD in annual operating expenses 2021, up 18.99% from previous year.
Alcon Inc. reported a quarterly operating expenses of 1.01 Billion USD for 2024 Q1, up 12.81% from previous quarter.
Alcon Inc. reported a quarterly operating expenses of 1.09 Billion USD for 2023 Q2, up 5.4% from previous quarter.

Annual Operating Expenses Chart of Alcon Inc. (2023 - 2015)

Historical Annual Operating Expenses of Alcon Inc. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	4.2 Billion USD	6.66%
2022	4.07 Billion USD	0.1%
2021	4.07 Billion USD	18.99%
2020	3.42 Billion USD	-11.09%
2019	3.84 Billion USD	11.89%
2018	3.44 Billion USD	4.85%
2017	3.28 Billion USD	5.8%
2016	3.1 Billion USD	13.91%
2015	2.72 Billion USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	1.05 Billion USD	4.14%
2024 Q1	1.01 Billion USD	12.81%
2023 Q2	1.09 Billion USD	5.4%
2023 Q4	898.87 Million USD	-9.75%
2023 Q3	996 Million USD	-8.87%
2023 Q1	1.03 Billion USD	-9.75%
2023 FY	4.34 Billion USD	6.66%
2022 Q4	1.14 Billion USD	19.56%
2022 FY	4.07 Billion USD	0.1%
2022 Q3	961 Million USD	-4.28%
2022 Q1	962 Million USD	-6.05%
2022 Q2	1 Billion USD	4.37%
2021 Q1	882 Million USD	20.16%
2021 Q3	1.17 Billion USD	18.57%
2021 FY	4.07 Billion USD	18.99%
2021 Q4	1.02 Billion USD	-12.85%
2021 Q2	991 Million USD	12.36%
2020 Q4	734 Million USD	-24.87%
2020 Q1	900 Million USD	-8.26%
2020 Q2	811 Million USD	-9.89%
2020 Q3	977 Million USD	20.47%
2020 FY	3.42 Billion USD	-11.09%
2019 Q4	981 Million USD	1.34%
2019 Q2	1 Billion USD	11.11%
2019 Q1	900 Million USD	-5.66%
2019 FY	3.84 Billion USD	11.89%
2019 Q3	968 Million USD	-3.2%
2018 Q2	840 Million USD	-0.41%
2018 FY	3.44 Billion USD	4.85%
2018 Q4	954 Million USD	11.97%
2018 Q3	852 Million USD	1.43%
2018 Q1	843.5 Million USD	-4.47%
2017 Q4	883 Million USD	0.0%
2017 FY	3.28 Billion USD	5.8%
2016 FY	3.1 Billion USD	13.91%
2015 FY	2.72 Billion USD	0.0%

Peer Operating Expenses Comparison of Alcon Inc.

Name	Operating Expenses	Operating Expenses Difference
AptarGroup, Inc.	814.37 Million USD	-416.715%
Baxter International Inc.	5.27 Billion USD	20.182%
Becton, Dickinson and Company	6.04 Billion USD	30.412%
Bausch + Lomb Corporation	2.37 Billion USD	-77.254%
Haemonetics Corporation	526.66 Million USD	-698.99%
Envista Holdings Corp	1.15 Billion USD	-265.69%
ResMed Inc.	1.36 Billion USD	-207.518%
Teleflex Incorporated	1.08 Billion USD	-288.114%
Warby Parker Inc.	437.22 Million USD	-862.445%
West Pharmaceutical Services, Inc.	454 Million USD	-826.872%